Behçet's disease: An algorithmic approach to its treatment

Archives of Dermatological Research

Volumn 301, Issue 10, 2009, Pages 693-702

  Alpsoy, Erkan ^a   Akman, Ayse ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Algorithmic approach; Articular symptoms; Beh et's disease; Gastrointestinal symptoms; Mucocutaneous symptoms; Neurologic symptoms; Ocular symptoms; Treatment

Indexed keywords

AMLEXANOX; ANTIINFECTIVE AGENT; BENZATHINE PENICILLIN; BENZYDAMINE; CEFALEXIN; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DICLOFENAC; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYDRIATIC AGENT; PENICILLIN G; PREDNISOLONE; RECOMBINANT ALPHA2A INTERFERON; TETRACYCLINE; TRIAMCINOLONE ACETONIDE;

AMENORRHEA; ARTHRITIS; BEHCET DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DYSMENORRHEA; HAIR LOSS; HEMATOLOGIC DISEASE; HUMAN; MALAISE; MICROBIAL CONTAMINATION; MORBIDITY; MORTALITY; NAUSEA; OLIGOSPERMIA; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; TREATMENT RESPONSE; VOMITING;

ADRENAL CORTEX HORMONES; BEHCET SYNDROME; BLOOD VESSELS; CLINICAL TRIALS AS TOPIC; CYCLOPHOSPHAMIDE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSION; MUCOUS MEMBRANE; MULTIPLE ORGAN FAILURE; PRACTICE GUIDELINES AS TOPIC; SKIN;

EID: 70349621090     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0990-2     Document Type: Short Survey

References (63)

1. M Addy R Carpenter WR Roberts 1976 Management of recurrent aphthous ulceration. A trial of chlorhexidine gel Br Dent J 141 118 120 786339 10.1038/sj.bdj.4803798
2. YD Adler U Mansmann CC Zouboulis 2001 Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease Dermatology 203 322 324 11752821 10.1159/000051781 (Pubitemid 34045195)
3. A Akman H Kacaroglu L Donmez A Bacanli E Alpsoy 2007 Relationship between periodontal findings and Behcet's disease: a controlled study J Clin Periodontol 34 485 491 17451414 10.1111/j.1600-051X.2007.01085.x
4. A Akman N Sallakci H Kacaroglu, et al. 2008 Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease J Eur Acad Dermatol Venereol 22 8 950 957 18355201 10.1111/j.1468-3083.2008.02678.x
5. E Aktulga M Altac A Muftuoglu, et al. 1980 A double blind study of colchicine in Behcet's disease Haematologica 65 399 402 6778795
6. E Alpsoy 2005 Behçet's disease: treatment of mucocutaneous lesions Clin Exp Rheumatol 23 532 539 16095126
7. E Alpsoy A Akman 2006 Treatment of Behçet's disease Therapy 3 139 151
8. E Alpsoy M Aktekin H Er C Durusoy E Yilmaz 1998 A randomized, controlled and blinded study of papulopustular lesions in Turkish Behcet's patients Int J Dermatol 37 839 843 9865870 10.1046/j.1365-4362.1998.00401.x (Pubitemid 28545277)
9. E Alpsoy L Donmez A Bacanli C Apaydin B Butun 2003 Review of the clinical manifestations' chronology in 60 patients with Behçet's disease Dermatology 117 354 356 10.1159/000074113 (Pubitemid 37505781)
10. E Alpsoy L Donmez M Onder, et al. 2007 Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study Br J Dermatol 157 901 906 17711526 10.1111/j.1365-2133.2007.08116.x (Pubitemid 47583484)
11. E Alpsoy C Durusoy E Yilmaz, et al. 2002 Interferon alpha-2a in the treatment of Behçet disease: a randomized, placebo-controlled and double blind study Arch Dermatol 138 467 471 11939808 10.1001/archderm.138.4.467
12. E Alpsoy H Er C Durusoy E Yilmaz 1999 The use of sucralfate suspension in the treatment of oral and genital ulcerations of Behçet's disease: a randomised, placebo-controlled and double-blind study Arch Dermatol 135 529 532 10328192 10.1001/archderm.135.5.529 (Pubitemid 29222295)
13. E Alpsoy CC Zouboulis CE Ehrlich 2007 Mucocutaneous lesions of Behçet's disease Yonsei Med J 48 573 585 17722228 10.3349/ymj.2007.48.4. 573 (Pubitemid 47499971)
14. MM Al-Waiz KE Sharquie MH A-Qaissi RK Hayani 2005 Colchicine and benzathine penicillin in the treatment of Behcet disease: a case comparative study Dermatol Online J 11 3 3 16409899
15. Assaad-Khalil SH (1991) Low-dose cyclosporin in Behçet's disease: follow-up controlled study with emphasis on extraocular manifestations and neuro-Behçet's disease. In: O'Duffy JD, Kokmen E (eds) Behçet's disease: basic and clinical aspects. Marcel Dekker, New York, pp 603-612
16. G Azizlerli AA Kose R Sarica, et al. 2003 Prevalence of Behcet's disease in Istanbul, Turkey Int J Dermatol 42 803 806 14521694 10.1046/j.1365-4362.2003. 01893.x (Pubitemid 37304045)
17. A Bacanli O Yerebakan B Parmaksizoglu E Yilmaz E Alpsoy 2006 Topical granulocyte-colony stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease J Eur Acad Dermatol Venereol 20 931 935 16922940
18. D Bang 1997 Treatment of Behcet's disease Yonsei Med J 38 401 410 9509910
19. D BenEzra E Cohen T Chajek, et al. 1988 Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome Transplant Proc 20 136 143 3381269
20. WH Binnie FA Curro A Khandwala RG Van Inwegan 1997 Amlexanox oral paste: a novel treatment that accelerates the healing of aphthous ulcers Compend Contin Educ Dent 18 1116 1124 9533345
21. M Calguneri I Ertenli S Kiraz M Erman I Celik 1996 Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease Dermatology 192 125 128 8829493
22. RJ Conklin B Blasberg 1991 Common inflammatory diseases of the mouth Int J Dermatol 30 323 335 2066189 10.1111/j.1365-4362.1991.tb03869.x
23. F Davatchi F Shahram H Chams M Akbarian 1999 Pulse cyclophosphamide (PCP) for ocular lesions of Behçet's disease: double blind crossover study Arthritis Rheum 42 S320
24. F Davatchi F Shahram H Chams, et al. 2003 High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results Adv Exp Med Biol 528 579 584 12918769 10.1007/0-306-48382-3-118
25. J Elidan E Cohen H Levi D BenEzra 1991 Effect of cyclosporine A on the hearing loss in Behçet's disease Ann Otol Rhinol Laryngol 100 464 468 2058987
26. M Gorsky J Epstein S Rabenstein H Elishoov N Yarom 2007 Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study Dermatol Online J 13 1 17498420
27. EA Graykowski A Kingman 1978 Double-blind trial of tetracycline in recurrent aphthous ulceration J Oral Pathol 7 376 382 105096 10.1111/j.1600-0714.1978.tb01605.x
28. RO Greer Jr JE Lindenmuth T Juarez A Khandwala 1993 A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers J Oral Maxillofac Surg 51 243 248 8445464
29. A Gurler A Boyvat U Tursen 1997 Clinical manifestations of Behcet's disease: an analysis of 2147 patients Yonsei Med J 38 423 427 9509912
30. V Hamuryudan C Mat S Saip, et al. 1998 Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial Ann Intern Med 128 443 450 9499327
31. V Hamuryudan F Moral S Yurdakul, et al. 1994 Systemic interferon alpha 2b treatment in Behçet's syndrome J Rheumatol 21 1098 1100 7932420
32. G Hatemi A Silman D Bang, et al. 2008 EULAR recommendations for the management of Behcet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 67 1656 1662 18245110 10.1136/ard.2007.080432
33. JL Jorizzo WL White CM Wise MD Zanolli EF Sherertz 1991 Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease J Am Acad Dermatol 24 973 978 1678395 10.1016/0190-9622(91)70156-V
34. H Kikuchi K Aramaki S Hirohata 2003 Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years Adv Exp Med Biol 528 575 578 12918768 10.1007/0-306-48382-3-117
35. AR Kerr CA Drexel AI Spielman 2003 The efficacy and safety of 50 mg penicillin G potassium troches for recurrent aphthous ulcers Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 685 694 14676759 10.1016/j.tripleo.2003.08.024 (Pubitemid 37550075)
36. I Kötter I Günaydin M Batra, et al. 2006 CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications-results of a retrospective analysis of 117 cases Clin Rheumatol 25 482 486 16261281 10.1007/s10067-005-0070-8 (Pubitemid 44137619)
37. I Kötter M Zierhut AK Eckstein, et al. 2003 Human recombinant interferon-alpha2a for the treatment of Behçet's disease with sight-threatening posterior or panuveitis Br J Ophthalmol 87 423 431 12642304 10.1136/bjo.87.4.423 (Pubitemid 36399030)
38. E Kural-Seyahi I Fresko N Seyahi, et al. 2003 The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine (Baltimore) 82 60 76 10.1097/00005792-200301000-00006 (Pubitemid 36139801)
39. K Masuda A Nakajima A Urayama K Nakae M Kogure G Inaba 1989 Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease Lancet 20 1093 1096 10.1016/S0140-6736(89)92381-7
40. C Mat S Yurdakul Y Ozyazgan S Uysal O Uysal H YazIcI 2006 A double-blind trial of depot corticosteroids in Behçet's syndrome Rheumatology (Oxford) 45 348 352 10.1093/rheumatology/kei165 (Pubitemid 43372853)
41. T Matsuda S Ohno S Hirohata, et al. 2003 Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study Drugs RD 4 19 28 10.2165/00126839-200304010-00002 (Pubitemid 37062641)
42. TF Meiller MJ Kutcher CD Overholser C Niehaus LG DePaola MA Siegel 1991 Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations Oral Surg Oral Med Oral Pathol 72 425 429 1923440 10.1016/0030-4220(91)90553-O
43. M Melikoglu I Fresko C Mat, et al. 2005 Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study J Rheumatol 32 98 105 15630733
44. B Mushtaq T Saeed RD Situnayake PI Murray 2007 Adalimumab for sight-threatening uveitis in Behçet's disease Eye 21 6 824 825 16601736 10.1038/sj.eye.6702352 (Pubitemid 46909189)
45. P Neri C Mariotti L Cimino L Mercanti A Giovannini 2009 Long-term control of cystoid macular oedema in noninfectious uveitis with mycophenolate mofetil Int Ophthalmol 29 127 133 18297240 10.1007/s10792-008-9200-z
46. S Ohno S Nakamura S Hori, et al. 2004 Efficacy, safety and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis J Rheumatol 31 1362 1368 15229958
47. Y Ozyazgan S Yurdakul H Yazici, et al. 1992 Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial Br J Ophthalmol 76 241 243 1390495 10.1136/bjo.76.4.241
48. T Sakane M Takeno N Suziki G Inaba 1999 Behcet's disease N Engl J Med 341 1284 1291 10528040 10.1056/NEJM199910213411707 (Pubitemid 29489745)
49. MA Saxen WT Ambrosius KF Rehemtula al AL Russell GJ Eckert 1997 Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 356 361 9347497 10.1016/S1079-2104(97)90031-7
50. PP Sfikakis PH Kaklamanis A Elezoglou, et al. 2004 Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease Ann Intern Med 140 404 406 14996689
51. PP Sfikakis N Markomichelakis E Alpsoy, et al. 2007 Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations Rheumatology (Oxford) 46 5 736 741 10.1093/rheumatology/kem034 (Pubitemid 47061701)
52. KE Sharquie RA Najim AR Abu-Raghif 2002 Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study J Dermatol 29 267 279 12081158
53. KE Sharquie RA Najim WS Al-Dori RK Al-Hayani 2006 Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study J Dermatol 33 541 546 16923135
54. A Siva A Altintas S Saip 2004 Behçet's syndrome and the nervous system Curr Opin Neurol 17 347 357 15167071 10.1097/00019052-200406000-00017 (Pubitemid 38720989)
55. AB Skaare BB Herlofson P Barkvoll 1996 Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU) J Clin Periodontol 23 778 781 8877665 10.1111/j.1600-051X.1996.tb00609.x
56. H Suda 1999 Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease Nihon Rinsho Meneki Gakkai Kaishi 22 13 22 11185687
57. I Tugal-Tutkun E Guney-Tefekli M Urgancioglu 2006 Results of interferon-alfa therapy in patients with Behcet uveitis Graefes Arch Clin Exp Ophthalmol 244 1692 1695 16673135 10.1007/s00417-006-0346-y (Pubitemid 44830831)
58. I Tugal-Tutkun A Mudun M Urgancioglu, et al. 2005 Efficacy of infliximab in the treatment of uveitis that is refractory to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease. An open-label trial Arthritis Rheum 52 2478 2484 16052571 10.1002/art.21231 (Pubitemid 41117435)
59. DH Verity GR Wallace PT Seed, et al. 1998 Soluble adhesion molecules in Behcet's disease Ocul Immunol Inflamm 6 81 92 9689638 10.1076/ocii.6.2.81.4054 (Pubitemid 28380072)
60. H Yazici H Pazarli CG Barnes, et al. 1990 A controlled trial of azathioprine in Behcet's syndrome N Engl J Med 322 281 285 2404204 (Pubitemid 20046329)
61. S Yurdakul V Hamuryudan H Yazici 2004 Behcet syndrome Curr Opin Rheumatol 16 38 42 14673387 10.1097/00002281-200401000-00008 (Pubitemid 38041397)
62. S Yurdakul C Mat Y Tuzun, et al. 2001 A double-blind trial of colchicine in Behcet's syndrome Arthritis Rheum 44 2686 2692 11710724 10.1002/1529- 0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H (Pubitemid 33049346)
63. CC Zouboulis I Kötter D Djawari, et al. 1997 Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe Yonsei Med J 38 411 422 9509911